200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 35543-24-9

35543-24-9

35543-24-9 | Buflomedil hydrochloride

CAS No: 35543-24-9 Catalog No: AG003DT5 MDL No:MFCD00078965

Product Description

Catalog Number:
AG003DT5
Chemical Name:
Buflomedil hydrochloride
CAS Number:
35543-24-9
Molecular Formula:
C17H26ClNO4
Molecular Weight:
343.8456
MDL Number:
MFCD00078965
IUPAC Name:
4-pyrrolidin-1-yl-1-(2,4,6-trimethoxyphenyl)butan-1-one;hydrochloride
InChI:
InChI=1S/C17H25NO4.ClH/c1-20-13-11-15(21-2)17(16(12-13)22-3)14(19)7-6-10-18-8-4-5-9-18;/h11-12H,4-10H2,1-3H3;1H
InChI Key:
ZDPACSAHMZADFZ-UHFFFAOYSA-N
SMILES:
COc1cc(OC)cc(c1C(=O)CCC[NH+]1CCCC1)OC.[Cl-]
EC Number:
252-611-9
UNII:
3J944AFS8S
NSC Number:
759291

Properties

Complexity:
330  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
343.155g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
343.848g/mol
Monoisotopic Mass:
343.155g/mol
Rotatable Bond Count:
8  
Topological Polar Surface Area:
48A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011. Pharmacoepidemiology and drug safety 20121101
[Microbial transformation of buflomedil by Cunninghamella blakesleana AS 3.153]. Yao xue xue bao = Acta pharmaceutica Sinica 20120701
The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study. Fundamental & clinical pharmacology 20120401
Vasoactive agent buflomedil up-regulated expression of vascular endothelial growth factor in a rat model of sciatic nerve crush injury. Indian journal of pharmacology 20120101
Safety of subcutaneous microinjections (mesotherapy) in musicians. Medical problems of performing artists 20110601
Effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy. International angiology : a journal of the International Union of Angiology 20110401
Buflomedil: still too many fatal cardiac and neurological events. Prescrire international 20110401
A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite. The New England journal of medicine 20110113
Influence of pharmacological treatment on blood flow and muscle perfusion in patients with obliterative atheromatosis assessed with isotopic methods. A pilot study. Medical science monitor : international medical journal of experimental and clinical research 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
[Addition of antithrombosis in situ in the case of digital replantation: preliminary prospective study of 13 cases]. Chirurgie de la main 20101001
[Multicentric study of thrombosis prevention in upper-extremity microsurgery. Survey at the Fesum centers]. Chirurgie de la main 20100401
Effects of buflomedil and pentoxifylline on hamster skin-flap microcirculation: prediction of flap viability using orthogonal polarization spectral imaging. Clinics (Sao Paulo, Brazil) 20090801
Buflomedil: potential new indications for an old agent. International angiology : a journal of the International Union of Angiology 20090601
Pharmacologic therapy for intermittent claudication. Pharmacotherapy 20090501
Cutaneous granulomatous reaction from mesotherapy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20090201
Bias in benefit-risk appraisal in older products: the case of buflomedil for intermittent claudication. Drug safety 20090101
Letter by De Backer et al regarding article, 'Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study'. Circulation 20080902
Simultaneous FTIR spectroscopic imaging and visible photography to monitor tablet dissolution and drug release. Pharmaceutical research 20080401
The use of buflomedil in reduction mammaplasty for a previously irradiated breast: a case report. Aesthetic plastic surgery 20080301
Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. Circulation 20080212
Buflomedil in peripheral arterial disease: trials and tribulations. Circulation 20080212
Buflomedil for intermittent claudication. The Cochrane database of systematic reviews 20080123
Buflomedil for intermittent claudication. The Cochrane database of systematic reviews 20071017
Buflomedil: still seizures and cardiac disorders. Too many patients are exposed to an unjustified risk of serious adverse effects. Prescrire international 20070201
Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis. Minerva cardioangiologica 20060601
The effects of prostaglandin E-1 in patients with intermittent claudication. Cardiovascular & hematological disorders drug targets 20060601
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Assemblage of novel release modules for the development of adaptable drug delivery systems. Journal of controlled release : official journal of the Controlled Release Society 20060310
Facilitated column selection in pharmaceutical analyses using a simple column classification system. Journal of chromatography. A 20060106
Buflomedil and pentoxifylline in the viability of dorsal cutaneous flaps of rats treated with nicotine. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 20060101
[Severe peripheral ischemia of rare origin]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20060101
Effect of loading on a swelling-controlled drug delivery system studied by optical techniques. Journal of controlled release : official journal of the Controlled Release Society 20050103
Protective effect of buflomedil in a rat model of moderate cerebral ischemia. Arzneimittel-Forschung 20050101
Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat. Neuroscience letters 20040902
[Secondary prevention and conservative therapy of obliterative arteriosclerosis]. Orvosi hetilap 20040516
Suicide by buflomedil HCl: a case report. Journal of clinical forensic medicine 20040201
[Suicidal buflomedil intoxication]. Archiv fur Kriminologie 20040101
Rapid HPLC measurement of buflomedil in plasma in poisoning cases. Biomedical chromatography : BMC 20021001
Rheological and biochemical examination of red blood cells after treatment with different pharmacological and toxic substances. Clinical hemorheology and microcirculation 20020101
[Sudden hearing loss. Clinical case]. Anales otorrinolaringologicos ibero-americanos 20020101
Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication. International angiology : a journal of the International Union of Angiology 20011201
[Retrograde venous perfusion (RVP in ulcero-mutilating neuropathy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20011001
[Clinical study of the effect of buflomedil on peripheral neuropathy in diabetic patients]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University 20010628
[Myoclonic coma and severe cardiac insufficiency in a patient with arteritis]. La Revue de medecine interne 20010601
Effects of buflomedil on early carotid atherosclerosis in Type 2 diabetic patients. International angiology : a journal of the International Union of Angiology 20010601
Heparin protects local skin microcirculation in 210 minutes-long intravital microscopy observations under general anaesthesia. European journal of medical research 20010420
Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. Journal of controlled release : official journal of the Controlled Release Society 20010223
Buflomedil for intermittent claudication. The Cochrane database of systematic reviews 20010101
Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents. The Journal of international medical research 19890101
[Emetic and catalepsy-inducing actions of buflomedil]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19881201

Related Products

© 2019 Angene International Limited. All rights Reserved.